|
Market Closed -
Nasdaq Stockholm
09:30:00 09/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 7.490 SEK | +4.61% |
|
-10.19% | -44.52% |
| 24/09 | Vivesto to present Paccal Vet data at conference | FW |
| 24/09 | Vivesto AB Presents Paccal Vet Data At The Veterinary Cancer Society Annual Conference 2026 | CI |
| Market Cap | 8.29Cr 82.93L 74.07L 68.9L 62.67L 1.18Cr 80Cr 1.19Cr 3.25Cr 41Cr 3.11Cr 3.05Cr 131.31Cr | P/E 2026 * |
-2.49x | P/E 2027 * | -2.07x |
|---|---|---|---|---|---|
| Enterprise Value | 7.49Cr 74.93L 66.92L 62.25L 56.62L 1.07Cr 73Cr 1.07Cr 2.94Cr 37Cr 2.81Cr 2.75Cr 118.65Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| VIVE | Delayed | |
Deutsche Boerse AG
| OMA | Delayed | |
|
CBOE
| 0N4A | Real-time | |
|
CBOE
| OASMs | Real-time | |
|
Börse Stuttgart
| OMA | Delayed |
Last Transcript: Vivesto AB
| 1 day | +4.61% | ||
| 1 week | -10.19% | ||
| Current month | -10.94% | ||
| 1 month | -16.59% | ||
| 3 months | -11.36% | ||
| 6 months | -3.23% | ||
| Current year | -44.52% |
| 1 week | 7 |  | 8.48 |
| 1 month | 7 | | 10 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 27.3 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/03/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/03/22 | Others | Chairman | 1,20,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 22,50,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.61% | -10.19% | -67.58% | -65.32% | 82.93L | |
| +0.83% | +3.19% | +41.49% | +103.56% | 1,05100Cr | |
| +1.93% | +2.11% | +37.08% | +65.09% | 63TCr | |
| +1.49% | +5.19% | +19.94% | +85.69% | 49TCr | |
| +2.26% | +0.90% | +69.32% | +40.53% | 36TCr | |
| +1.45% | +3.50% | +23.29% | +41.62% | 34TCr | |
| +1.17% | +2.37% | +13.47% | +33.64% | 27TCr | |
| +0.89% | +1.08% | -6.13% | +9.29% | 25TCr | |
| +1.82% | +2.94% | +42.99% | +52.95% | 22TCr | |
| +2.77% | +4.44% | +29.01% | +98.99% | 19TCr | |
| Average | +1.92% | +1.26% | +20.29% | +46.60% | 38.04TCr | |
| Weighted average by Cap. | +1.47% | +2.44% | +33.36% | +69.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.1Cr -31L -27.69L -25.76L -23.43L -44.24L -30Cr -44.43L -1.21Cr -15Cr -1.16Cr -1.14Cr -49Cr | -4Cr -40L -35.73L -33.23L -30.23L -57.08L -39Cr -57.32L -1.57Cr -20Cr -1.5Cr -1.47Cr -63Cr |
| Net Debt | -80L -8L -7L -7L -6L -11.42L -7.74Cr -11.46L -31.35L -3.95Cr -30.04L -29.39L -13Cr | -1.7Cr -17L -15.18L -14.12L -12.85L -24.26L -16Cr -24.36L -66.61L -8.39Cr -63.84L -62.45L -27Cr |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | SEK 7.490 | +4.61% | 5,072 |
| 08/26/08 | SEK 7.160 | -1.10% | 1,819 |
| 07/26/07 | SEK 7.240 | -7.30% | 17,751 |
| 06/26/06 | SEK 7.810 | -1.14% | 2,528 |
| 05/26/05 | SEK 7.900 | -5.28% | 5,805 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
